For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on March 28th, 2024 | 08:55 CET
Shares on a high: Up to 300% with Canopy Growth, Super Micro Computer, Aspermont
Is the German cannabis market on the verge of a tenfold increase? The head of Canopy Growth thinks so. The Company wants to profit from the boom. Canopy shares have already benefited and more than doubled. What are the Company's plans here in Germany? Super Micro Computer shares have already multiplied, but analysts remain bullish. Growth is expected to remain high. Aspermont offers a hot turnaround story. The B2B media company for the raw materials industry has freed itself from legacy burdens and now aims to grow more strongly again. Analysts see a high free cash flow and 300% share price potential!
Read
Commented by Fabian Lorenz on March 27th, 2024 | 08:45 CET
Shares in Focus: TUI, Rheinmetall, and Defense Metals with good reasons for price increases
The TUI share was one of the top performers on the German stock market yesterday. The EUR 7 mark was exceeded, making things exciting on the chart. Analysts expect significantly higher prices for the tourism group. Rheinmetall shares are among the top performers of the year. An end to the price increase is not in sight. The armaments group has announced a new order worth billions. The manufacture of armaments, aircraft, cruise ships and numerous other high-tech products would not be possible without rare earths. However, most of these come from China and Russia. This makes the Defense Metals share interesting. The Company is making great strides with its rare earths project in Canada. The share should also benefit from this progress.
Read
Commented by Fabian Lorenz on March 26th, 2024 | 07:00 CET
Out of BioNTech and into Defence Therapeutics and Evotec shares?
The BioNTech share is currently out of steam. Although sentiment in the sector is improving, as star investor Cathie Wood recently invested in Moderna, the German biotech leader is not making any headway. The latest figures have not convinced analysts, and the price targets have even been further reduced. In contrast, the shares of Defence Therapeutics and Evotec appear to have more upside momentum. The Canadian cancer specialist has just raised new capital to develop its exciting pipeline. The Company has recently been granted a new US patent for its approach to cancer therapy. Evotec has a "Buy" recommendation. Could this mean the share is on the verge of an upward trend?
Read
Commented by Fabian Lorenz on March 21st, 2024 | 07:00 CET
Big hits for BYD, Bitcoin Group and the Carbon Done Right Developments share
Bitcoin is not for the faint-hearted. Following the rapid rise to a new all-time high of USD 73,000, the cryptocurrency has fallen by USD 10,000 in just a few days. The Bitcoin Group share is also feeling the effects of this. Analysts anticipate that the trading platform will significantly increase its turnover in 2024. Carbon Done Right Developments is currently going from strength to strength. Following its renaming, the Company now wants to acquire a blockchain-supported trading platform for emission certificates and is seeking a secondary listing of its shares in London. The share is anything but expensive. One analyst's target price for BYD shares has caused a sensation. Accordingly, there is more than 100% upside potential. Sales figures and margins should recover quickly. The Chinese company is also focusing on Europe. The car manufacturer will be the main sponsor of the upcoming European Football Championship, is building a factory in Hungary, and aims to multiply its sales.
Read
Commented by Fabian Lorenz on March 20th, 2024 | 07:45 CET
Buying opportunity for HelloFresh and Plug Power? When will the dynaCERT share breakthrough happen?
HelloFresh shares have already lost over 50% of their value in 2024. It should be time for a countermovement, but there is currently no sign of it. One analyst believes the share price could rise by almost 100%. However, he is pretty much alone in this prediction. There are also few optimists at Plug Power at the moment. And from tomorrow, the path to profitability will be a little further away for the hydrogen specialist. In contrast, dynaCERT has been showing relative strength for months. The order intake is decent, and an event should trigger the breakthrough for the share.
Read
Commented by Fabian Lorenz on March 14th, 2024 | 06:30 CET
Aixtron, Standard Lithium, Edison Lithium: Up to 200% upside potential!
The Aixtron share is working on a comeback. The last few trading days have been positive, and an analyst commentary also gives hope that the crash is over. After all, the medium-term prospects of the plant engineering company are considered promising. Lithium also appears to be recovering. The long-term prospects for the sector are promising. In the case of Standard Lithium, support at USD 1 has held, and analysts see a price potential of more than 200%. At Edison Lithium, a spin-off is creating price fantasy. Will the IPO of the cobalt business bring about a turnaround? In its core business, the Company is focusing on the raw material for the next generation of batteries.
Read
Commented by Fabian Lorenz on March 13th, 2024 | 06:30 CET
Bayer disappoints, BioNTech share gives hope, and Cardiol Therapeutics with upside potential!
Analysts were anticipating a more favourable outcome from Bayer's Capital Markets Day. While the spin-off of Aspirin and Co. was expected, and there was also more transparency in the legal disputes, the actual results differed significantly. In some cases, analysts' share price targets plummeted by nearly 50%. In contrast, analysts have renewed their "Buy" recommendation for Cardiol Therapeutics shares. The specialist in cardiovascular diseases is facing exciting weeks and the share could certainly still more than double. There is also movement at BioNTech. In addition to operating figures, there will soon be an update on the drug pipeline. The question remains whether the share can halt its downward trend.
Read
Commented by Fabian Lorenz on March 7th, 2024 | 06:45 CET
Buy recommendations for TUI and Saturn Oil + Gas share - Aixtron share price targets tumble
TUI was among the daily winners yesterday. The tourism group's share price rose by more than 5%. The reason was positive analyst commentary. The price target was raised, providing significant upside potential from the current level. Experts also recommend buying Saturn Oil & Gas. After a successful capital increase, the target price for the oil producer's shares was raised. Analysts see over 100% upside potential and scope for high dividends. At Aixtron, analysts' price targets are tumbling. There is even a sell recommendation. However, not all analysts are pessimistic; some see an opportunity in the price slide of the past few days.
Read
Commented by Fabian Lorenz on March 6th, 2024 | 11:30 CET
Hydrogen news: Nel shares "Sell", Thyssenkrupp Nucera "Buy", and First Hydrogen convinces customers
Are Nel shares at risk of another price slide? The Norwegians failed to impress with their figures for the fourth quarter and the full year 2023. Incoming orders, in particular, are a cause for concern. Analysts see further downside potential for the share, but there are also optimists. In contrast, the hydrogen newcomer First Hydrogen, which specializes in commercial vehicles, is convincing. In the UK, there was no loss of range even during use in the cold season. Owners of Tesla, Volkswagen and the like can only dream of this. If concrete orders follow, the share should be able to take off. Analysts see potential for Thyssekrupp Nucera shares. The development in the first quarter was convincing. However, investors should also scrutinize the developments in the German hydrogen hopeful.
Read
Commented by Fabian Lorenz on February 29th, 2024 | 08:00 CET
Renk, Hensoldt and Desert Gold: Price gains with armaments and gold
German defense stocks are currently in high demand. Rheinmetall shares have already gained 40% in the current year, while Hensoldt achieved a performance of 35% in the first two months of 2024. The figures for 2023 only dampened the mood briefly. What do analysts say about Hensoldt's share price potential? Stock market newcomer Renk still has to establish itself. But the IPO is beginning to bear fruit. Gold shares should also benefit from the global uncertainties. However, the performance of Barrick & Co. in recent years has been disappointing. Desert Gold could become the surprise stock of the year. According to experts, the explorer was the talk of the town at the recently concluded Mining INDABA trade fair in Cape Town, South Africa.
Read